Discovery of S-217622, a Noncovalent Oral SARS-CoV-2 3CL Protease Inhibitor

With a successful vaccine roll out and boasters jabs in

Small Molecule CNS compounds for neuropathic pain "In general, neuropathic

Machine Learning May Sometimes Simply Capture Literature Popularity Trends: A

I guess I am blessed, I only live 7 miles

We know many biotechs and pharmaceutical companies work with Enamine

Dr Ed Griffen has given an interview to The Medicine

Leading compounds meet the criteria: The COVID Moonshot announced last

In this study, researchers from Boston College develop and then

In the course of our work towards an automated Structure

The January issue of J. Med. Chem is a bumper

New version in Production - v1.7.4 A new version of

Novel Bacterial Topoisomerase Inhibitors: Identification of a Lead with In

In his latest contribution, Peter Ertl analyses the ChEMBL database

After last year's successful 'end-of-year' webinar on Covid Moonshot, the

MedChemica's Dr Ed Griffen talks about the challenge of data

Artificial intelligence in drug discovery: what is realistic, what are

New recruits and new tools coming.... We would like to

ChEMBL29 - latest data... We have just completed our update

Discovery of 6-[(3S,4S)-4-Amino-3-methyl-2-oxa-8-azaspiro[4.5]decan-8-yl]-3-(2,3-dichlorophenyl)-2-methyl-3,4-dihydropyrimidin-4-one (IACS-15414), a Potent and Orally Bioavailable SHP2